These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7070698)

  • 1. [Atrial fibrillation and flutter in children].
    Battaglia T; Attanà A; Fumarulo A; Paparo F; Primerano M; Martini B
    Minerva Med; 1982 Apr; 73(14):855-8. PubMed ID: 7070698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conversion of atrial fibrillation and flutter by a combination of anti-arrhythmic drugs].
    Pidrman V; Hamet A
    Vnitr Lek; 1972 Sep; 18(9):845-8. PubMed ID: 4403993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of tachycardiac arrhythmias].
    Bender F
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():97-105. PubMed ID: 4191388
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of supraventricular tachycardia].
    Peters RW
    Recenti Prog Med; 1981 Jul; 71(1):48-68. PubMed ID: 6118917
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
    López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F
    Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative therapy of supraventricular tachycardias].
    Gmeiner R; Sterz H
    Wien Med Wochenschr; 1984 Oct; 134(19-20):443-7. PubMed ID: 6151320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment.
    Riva S; Tondo C; Carbucicchio C; Galimberti P; Fassini G; Della Bella P
    Europace; 1999 Oct; 1(4):242-7. PubMed ID: 11220561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of auricular flutter and fibrillation with amiodarone and digitalis].
    Ferrero C
    G Ital Cardiol; 1977; 7(10):1031. PubMed ID: 924055
    [No Abstract]   [Full Text] [Related]  

  • 11. [Programmed esophageal stimulation of the atrium and the long-term effects of anti-arrhythmia therapy of atrial fibrillation and flutter].
    Novotný E; Uhrová V; Suda J
    Vnitr Lek; 1995 Sep; 41(9):586-9. PubMed ID: 7483347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation].
    Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():87-96. PubMed ID: 7846950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antiarrhythmic drugs for atrial flutter and atrial fibrillation: a conceptual breakthrough at last?
    Cosío FG; Delpón E
    Circulation; 2002 Jan; 105(3):276-8. PubMed ID: 11804977
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use and mechanism of action of digitalis glycosides as anti-arrhythmic drugs].
    Nadeau R
    Acta Cardiol; 1977; Suppl 22():97-105. PubMed ID: 301694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The differentiated therapy of paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease in relation to the duration of the arrhythmia before the start of treatment].
    Shabrov AV; Olesin AI; Golub IaV; Smolin ZIu
    Ter Arkh; 1998; 70(8):25-9. PubMed ID: 9770739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of the antiarrhythmic effect of Verapamils].
    Filias N; Zanoni G
    Schweiz Med Wochenschr; 1972 Mar; 102(12):406-9. PubMed ID: 5020522
    [No Abstract]   [Full Text] [Related]  

  • 18. Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?
    Klein HO; Kaplinsky E
    Drugs; 1986 Mar; 31(3):185-97. PubMed ID: 3519173
    [No Abstract]   [Full Text] [Related]  

  • 19. Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutter.
    Kayser SR
    Prog Cardiovasc Nurs; 1997; 12(1):39-43. PubMed ID: 9058463
    [No Abstract]   [Full Text] [Related]  

  • 20. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2004 May; 93(9):1173-6. PubMed ID: 15110217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.